| Product Code: ETC7144461 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the therapeutic vaccines import market in Estonia continued to thrive with a high Herfindahl-Hirschman Index (HHI) indicating significant market concentration. The top exporting countries to Estonia were Lithuania, Finland, Germany, Sweden, and Poland, showcasing a diverse range of sources for these important medical products. The impressive Compound Annual Growth Rate (CAGR) of 16.41% from 2020 to 2024 reflects the increasing demand for therapeutic vaccines in Estonia. Moreover, the growth rate of 8.53% from 2023 to 2024 suggests a sustained momentum in the market, indicating a positive outlook for the future of therapeutic vaccines imports in the country.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Estonia Therapeutic Vaccines Market Overview |
3.1 Estonia Country Macro Economic Indicators |
3.2 Estonia Therapeutic Vaccines Market Revenues & Volume, 2022 & 2032F |
3.3 Estonia Therapeutic Vaccines Market - Industry Life Cycle |
3.4 Estonia Therapeutic Vaccines Market - Porter's Five Forces |
3.5 Estonia Therapeutic Vaccines Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Estonia Therapeutic Vaccines Market Revenues & Volume Share, By Therapeutic Vaccines, 2022 & 2032F |
4 Estonia Therapeutic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Estonia Therapeutic Vaccines Market Trends |
6 Estonia Therapeutic Vaccines Market, By Types |
6.1 Estonia Therapeutic Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Estonia Therapeutic Vaccines Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Estonia Therapeutic Vaccines Market Revenues & Volume, By Peptide Therapeutic Vaccine, 2022 - 2032F |
6.1.4 Estonia Therapeutic Vaccines Market Revenues & Volume, By Cell Therapeutic Vaccine, 2022 - 2032F |
6.1.5 Estonia Therapeutic Vaccines Market Revenues & Volume, By Nucleic Acid Therapeutic Vaccine, 2022 - 2032F |
6.2 Estonia Therapeutic Vaccines Market, By Therapeutic Vaccines |
6.2.1 Overview and Analysis |
6.2.2 Estonia Therapeutic Vaccines Market Revenues & Volume, By Oncotherapy, 2022 - 2032F |
6.2.3 Estonia Therapeutic Vaccines Market Revenues & Volume, By Hepatitis B, 2022 - 2032F |
6.2.4 Estonia Therapeutic Vaccines Market Revenues & Volume, By Tuberculosis, 2022 - 2032F |
6.2.5 Estonia Therapeutic Vaccines Market Revenues & Volume, By Herpes Simplex Virus, 2022 - 2032F |
6.2.6 Estonia Therapeutic Vaccines Market Revenues & Volume, By Others, 2022 - 2032F |
7 Estonia Therapeutic Vaccines Market Import-Export Trade Statistics |
7.1 Estonia Therapeutic Vaccines Market Export to Major Countries |
7.2 Estonia Therapeutic Vaccines Market Imports from Major Countries |
8 Estonia Therapeutic Vaccines Market Key Performance Indicators |
9 Estonia Therapeutic Vaccines Market - Opportunity Assessment |
9.1 Estonia Therapeutic Vaccines Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Estonia Therapeutic Vaccines Market Opportunity Assessment, By Therapeutic Vaccines, 2022 & 2032F |
10 Estonia Therapeutic Vaccines Market - Competitive Landscape |
10.1 Estonia Therapeutic Vaccines Market Revenue Share, By Companies, 2025 |
10.2 Estonia Therapeutic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here